Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis
Clinical Pharmacokinetics · 2026
DOI: 10.1007/s40262-026-01619-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacokinetics, 2026. Verfasst von Thi A Nguyen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Sydney, NSW, 2006, Australia. Hauptthemen laut MEDLINE: Levofloxacin, Saliva, Tuberculosis, Multidrug-Resistant, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council, National Foundation for Science and Technology Development, The University of Sydney.
Abstract (Originalsprache)
Background and Objectives Levofloxacin is an essential drug in multidrug-resistant tuberculosis (MDR-TB) treatment, but high pharmacokinetic variability necessitates therapeutic drug monitoring (TDM) to optimise exposure and improve outcomes. Traditional TDM requires invasive blood sampling, limiting feasibility. Saliva sampling, a non-invasive matrix may simplify implementation. We aimed to develop a levofloxacin population pharmacokinetic (popPK) model integrating plasma and saliva data, and to evaluate saliva-based limited sampling strategies to support model-informed TDM for levofloxacin in practice.
Methods
Adults receiving oral levofloxacin for ≥ 7 days had plasma and saliva samples collected at 0, 2, and 5 h post-dose. A plasma-and-saliva popPK model was developed using NONMEM, including covariate evaluation. Predictive performance of saliva-based limited sampling strategies for estimating plasma AUC24 was assessed using Bayesian estimation and Monte Carlo simulations.
Results
A total of 57 patients with 342 paired plasma-saliva samples were evaluated. One-compartment model incorporating saliva bio-compartment with first-order absorption (with a lag time) and elimination best described the data. No significant covariates were identified. Simulations showed that the three-point saliva strategy (0, 2, 5 h) predicted plasma AUC24 within clinically acceptable limit (< 15% prediction error). A single 2-h sample yielded comparable accuracy. Two- and three-sample saliva strategies up to 16 h post-dose also showed clinically acceptable accuracy.
Conclusions
The developed popPK model enables reliable estimation of levofloxacin exposure from limited saliva samples. A single 2-h post-dose saliva concentration may support model-informed levofloxacin TDM in routine MDR-TB care. This approach may be beneficial in settings where plasma-based TDM is logistically or ethically challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Pharmacy Building (A15), Sydney, NSW, 2006, Australia.
- Department of Pharmacy, Westmead Hospital, Sydney, NSW, Australia.
- Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Australia.
- Ho Chi Minh City University of Technology, Ho Chi Minh City, Vietnam.
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
- Woolcock Institute of Medical Research, Hanoi, Vietnam.
ORCID-Profile: Thi A Nguyen, Tri P Nguyen, Hoa D Vu, Jan-Willem C Alffenaar, Sophie L Stocker
Förderung
- National Health and Medical Research Council
- National Foundation for Science and Technology Development
- The University of Sydney
Zitieren
APA
Nguyen, T. A., Nguyen, T. P., Nguyen, A. T., Dinh, L. V., Nguyen, H. B., Vu, H. D., Nguyen, T. N. B., Vu, D., Fox, G. J., Alffenaar, J. C., & Stocker, S. L. (2026). Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-026-01619-3
Vancouver
Nguyen TA, Nguyen TP, Nguyen AT, Dinh LV, Nguyen HB, Vu HD, et al. Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis. Clinical Pharmacokinetics. 2026. doi:10.1007/s40262-026-01619-3
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thi A and Nguyen, Tri P and Nguyen, Anh T and Dinh, Luong V and Nguyen, Hoa B and Vu, Hoa D and Nguyen, Tram N B and Vu, Dang and Fox, Greg J and Alffenaar, Jan-Willem C and Stocker, Sophie L},
title = {Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis},
journal = {Clinical Pharmacokinetics},
year = {2026},
doi = {10.1007/s40262-026-01619-3}
}
EUVIMED